# Microsphere-Delivered Cytokines in Increasing Tumor Response in Lymphocytes From Patients With Head and Neck Cancer

> **NCT00899821** · NA · COMPLETED · sponsor: **NYU Langone Health**

## Conditions studied

- Head and Neck Cancer

## Interventions

- **BIOLOGICAL:** aldesleukin
- **BIOLOGICAL:** recombinant interleukin-12
- **BIOLOGICAL:** sargramostim
- **OTHER:** immunologic technique
- **PROCEDURE:** biopsy

## Key facts

- **NCT ID:** NCT00899821
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-06
- **Primary completion:** 2004-12
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2012-11-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00899821

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00899821, "Microsphere-Delivered Cytokines in Increasing Tumor Response in Lymphocytes From Patients With Head and Neck Cancer". Retrieved via AI Analytics 2026-09-24 from https://api.ai-analytics.org/clinical/NCT00899821. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*